Pediatric Asthma clinical trials

Explore recruiting pediatric asthma clinical trials.

Recruiting pediatric asthma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pediatric Asthma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.

Poland, France, Slovakia, Spain, Hungary, Germany +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Double-blind, randomized, active-controlled, two-way cross-over study, with 12-week treatment duration per period, to evaluate the efficacy and safety of QMF149 (indacaterol acetate / mometasone furoate) compared to budesonide in children from 6 to less than 12 years of age with asthma

Portugal, Hungary, Greece, Spain, Romania, Czechia +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, double-blind, placebo-controlled, parallel group study to assess the efficacy and long-term safety of dupilumab in children 2 to <6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze

Poland, Hungary, Czechia, Netherlands, Greece, Italy +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pediatric Asthma trials by city

Pediatric Asthma in Toronto Pediatric Asthma in Vancouver Pediatric Asthma in Montreal Pediatric Asthma in Calgary Pediatric Asthma in Edmonton Pediatric Asthma in Ottawa Pediatric Asthma in Winnipeg Pediatric Asthma in Quebec City Pediatric Asthma in Hamilton Pediatric Asthma in Kitchener Pediatric Asthma in London Pediatric Asthma in Halifax Pediatric Asthma in New York Pediatric Asthma in Los Angeles Pediatric Asthma in Chicago Pediatric Asthma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease